These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8162665)

  • 1. Lithium pharmacokinetics in the obese.
    Reiss RA; Haas CE; Karki SD; Gumbiner B; Welle SL; Carson SW
    Clin Pharmacol Ther; 1994 Apr; 55(4):392-8. PubMed ID: 8162665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a single non-timed urine collection in the calculation of fractional lithium clearance.
    O'Hagan M; Greene S
    Eur J Clin Pharmacol; 1990; 39(1):89-90. PubMed ID: 2276392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous ciprofloxacin disposition in obesity.
    Allard S; Kinzig M; Boivin G; Sörgel F; LeBel M
    Clin Pharmacol Ther; 1993 Oct; 54(4):368-73. PubMed ID: 8222478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose pharmacokinetics of lithium and prediction of maintenance dose in manic depressive patients.
    Valecha N; Tayal G; Tripathi KD
    Indian J Med Res; 1990 Dec; 92():409-16. PubMed ID: 2079355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG; Tsubaki T; Chandler MH
    Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating creatinine clearance in morbidity obese patients.
    Dionne RE; Bauer LA; Gibson GA; Griffen WO; Blouin RA
    Am J Hosp Pharm; 1981 Jun; 38(6):841-4. PubMed ID: 7246555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children.
    Lim SY; Woo S; Miller JL; Skrepnek GH; Henry ED; Johnson PN
    Pediatr Crit Care Med; 2019 Dec; 20(12):e556-e564. PubMed ID: 31568259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine disposition in obesity.
    Abernethy DR; Todd EL; Schwartz JB
    Br J Clin Pharmacol; 1985 Jul; 20(1):61-6. PubMed ID: 4027137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.
    Dvorchik BH; Damphousse D
    J Clin Pharmacol; 2005 Jan; 45(1):48-56. PubMed ID: 15601805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting lithium dose by the body-weight method.
    Groves GE; Clothier JL; Hollister LE
    Int Clin Psychopharmacol; 1991; 6(1):19-23. PubMed ID: 2071886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.
    Chung EK; Cheatham SC; Fleming MR; Healy DP; Kays MB
    J Clin Pharmacol; 2017 Mar; 57(3):356-368. PubMed ID: 27530916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of lithium.
    Jermain DM; Crismon ML; Martin ES
    Clin Pharm; 1991 May; 10(5):376-81. PubMed ID: 2049899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline disposition in obese rats.
    Shum L; Jusko WJ
    J Pharmacol Exp Ther; 1984 Feb; 228(2):380-6. PubMed ID: 6694116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden.
    Millischer V; Matheson GJ; Bergen SE; Coombes BJ; Ponzer K; Wikström F; Jagiello K; Lundberg M; Stenvinkel P; Biernacka JM; Breuer O; Martinsson L; Landén M; Backlund L; Lavebratt C; Schalling M
    Lancet Psychiatry; 2022 Jun; 9(6):447-457. PubMed ID: 35569502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects.
    Cheymol G; Woestenborghs R; Snoeck E; Ianucci R; Le Moing JP; Naditch L; Levron JC; Poirier JM
    Eur J Clin Pharmacol; 1997; 51(6):493-8. PubMed ID: 9112066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients.
    Chung EK; Cheatham SC; Fleming MR; Healy DP; Shea KM; Kays MB
    J Clin Pharmacol; 2015 Aug; 55(8):899-908. PubMed ID: 25823963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and safety of a priori lithium loading.
    Kook KA; Stimmel GL; Wilkins JN; Spangher GG
    J Clin Psychiatry; 1985 Feb; 46(2):49-51. PubMed ID: 3918024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.